KRAS and non-small cell lung carcinoma: In light of this, it is important to note that these data were gathered from a cell line with a genetic background absent of oncogenic driver mutations, HEK293T, whereas the NSCLC cell lines HCC827 and A4427 harbor activating oncogenic driver mutations in EGFR and KRAS, respectively.